Statement of Cash Flows |
2 Months Ended |
---|---|
May 31, 2024
USD ($)
| |
Alps Life Science Inc [Member] | |
CASH FLOWS USED IN OPERATING ACTIVITIES | |
Loss before tax | $ (6,441) |
Changes in working capital: | |
Other payable and accrued expense | 6,441 |
Net Cash Used In Operating Activities | |
NET DECREASE IN CASH AND CASH EQUIVALENTS | |
CASH AND CASH EQUIVALENTS AT BEGINNING OF THE FINANCIAL YEAR | |
CASH AND CASH EQUIVALENTS AT END OF THE FINANCIAL YEAR |
X | ||||||||||
- Definition Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities, from continuing and discontinued operations. [Refer: Revenue] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The profit (loss) before tax expense or income. [Refer: Profit (loss)] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Details
|